BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11942046)

  • 1. Prevention of liver cancer: current strategies and future perspectives.
    Moriwaki H
    Int J Clin Oncol; 2002 Feb; 7(1):27-31. PubMed ID: 11942046
    [No Abstract]   [Full Text] [Related]  

  • 2. Can a vitamin prevent hepatocellular carcinoma?
    Venook AP
    Hepatology; 1997 Jan; 25(1):249-50. PubMed ID: 8985300
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemoprevention of primary liver cancer.
    Buiatti E
    IARC Sci Publ; 1996; (136):41-3. PubMed ID: 8791114
    [No Abstract]   [Full Text] [Related]  

  • 4. Current strategies for chemoprevention of hepatocellular carcinoma.
    Okita K; Sakaida I; Hino K
    Oncology; 2002; 62 Suppl 1():24-8. PubMed ID: 11868781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of FGF signaling: a putative mechanism for the chemopreventive effects of acyclic retinoid in hepatocellular carcinoma.
    Wang L; Levin MS
    Gastroenterology; 2005 Jan; 128(1):228-31. PubMed ID: 15633140
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatocellular carcinoma: is there a potential for chemoprevention using cyclooxygenase-2 inhibitors?
    Koga H
    Cancer; 2003 Aug; 98(4):661-7. PubMed ID: 12910508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic retinoids for the secondary prevention of hepatocellular carcinoma.
    Shafritz DA
    N Engl J Med; 1996 Jun; 334(24):1600-1. PubMed ID: 8628344
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemoprevention of hepatocellular carcinoma by acyclic retinoid].
    Nagaki M; Shimizu M; Moriwaki H
    Nihon Shokakibyo Gakkai Zasshi; 2008 Jun; 105(6):802-7. PubMed ID: 18525185
    [No Abstract]   [Full Text] [Related]  

  • 9. Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma.
    Bishayee A; Politis T; Darvesh AS
    Cancer Treat Rev; 2010 Feb; 36(1):43-53. PubMed ID: 19910122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phytochemicals in hepatocellular cancer prevention.
    Nishino H
    Nutr Cancer; 2009; 61(6):789-91. PubMed ID: 20155617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An aspirin a day: the allure (and distraction) of chemoprevention.
    Levy IG; Pim CP
    J Natl Cancer Inst; 2012 Dec; 104(23):1782-4. PubMed ID: 23197493
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential role of lycopene in the treatment of hepatitis C and prevention of hepatocellular carcinoma.
    Seren S; Mutchnick M; Hutchinson D; Harmanci O; Bayraktar Y; Mutchnick S; Sahin K; Kucuk O
    Nutr Cancer; 2008; 60(6):729-35. PubMed ID: 19005972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vitamin K2 on the development of hepatocellular carcinoma in type C cirrhosis.
    Kojima K; Tamano M; Akima T; Hashimoto T; Kuniyoshi T; Maeda C; Majima Y; Kusano K; Murohisa T; Iijima M; Hiraishi H
    Hepatogastroenterology; 2010; 57(102-103):1264-7. PubMed ID: 21410069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of hepatocellular carcinoma by acyclic retinoid.
    Shimizu M; Sakai H; Moriwaki H
    Front Biosci (Landmark Ed); 2011 Jan; 16(2):759-69. PubMed ID: 21196201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of liver cancer by plant polyphenols.
    Stagos D; Amoutzias GD; Matakos A; Spyrou A; Tsatsakis AM; Kouretas D
    Food Chem Toxicol; 2012 Jun; 50(6):2155-70. PubMed ID: 22521445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins for chemoprevention of hepatocellular carcinoma: assessing the evidence.
    Siegel AB; El-Serag HB
    Expert Rev Gastroenterol Hepatol; 2013 Aug; 7(6):493-5. PubMed ID: 23984995
    [No Abstract]   [Full Text] [Related]  

  • 17. [Towards a chemoprevention of hepatocellular carcinoma?].
    Ganne-CarriƩ N; Christidis C; Beaugrand M
    Gastroenterol Clin Biol; 1997; 21(6-7):447-9. PubMed ID: 9295970
    [No Abstract]   [Full Text] [Related]  

  • 18. Apoptosis induction by acyclic retinoid: a molecular basis of 'clonal deletion' therapy for hepatocellular carcinoma.
    Okuno M; Sano T; Matsushima-Nishiwaki R; Adachi S; Akita K; Okano Y; Kojima S; Moriwaki H
    Jpn J Clin Oncol; 2001 Aug; 31(8):359-62. PubMed ID: 11574627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PPARgamma agonist pioglitazone inhibits early neoplastic occurrence in the rat liver.
    Borbath I; Leclercq I; Moulin P; Sempoux C; Horsmans Y
    Eur J Cancer; 2007 Jul; 43(11):1755-63. PubMed ID: 17582756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Where are we in the chemoprevention of hepatocellular carcinoma?
    Lu SC
    Hepatology; 2010 Mar; 51(3):734-6. PubMed ID: 20198627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.